Endometrium

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
55961
EORTC 55961,Phase II study on Paclitaxel in recurrent uterine papillary serous carcinoma (UPSC)
55962
A randomized phase III trial for evaluation of usefullness of pelvic drains after radical hysterectomy and node dissection (RHND)
55872
Randomized phase II protocol to study adriamycin/Cisplatin in combination and adriamycin alone in patients with advanced and/or recurrent endometrial carcinoma
55873
Randomized phase II protocol to study cyclophosphamide or Ifosfamide in patients with advanced and/or recurrent endometrial carcinoma
04861
Etude clinique phase II 4' -0-tetrahydropyranyl adriamycine (THP-ADM-1609 RB)
55853
Phase II trial of carboplatin in advanced/recurrent endometrial carcinoma
55839
Phase II Chemotherapy with Mitoxantrone for Recurrent and/or Disseminated Endometrial Carcinoma
55991
 A randomized trial of adjuvant treatment with radiation plus chemotherapy versus radiation alone in high risk endometrial carcinoma.
55984
A randomized trial of Adryamicin (A) Cisplatin (P) chemotherapy versus Paclitaxel (T) Adriamycin (A) and Cisplatin (P) in patients with metastatic/relapsed or locally advanced inoperable endometrial cancer.

Back to Site-list